EPN
EPSILON HEALTHCARE LIMITED
$0.0240
0.00%
Market cap
$9M
Turnover
$1,680
Last price
$0.0240
Day change
0.00%
Announcements
5
Range, past year
Open 0.024 · Low 0.019 · Now 0.024 · High 0.040
Open EPN in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
EPN momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
27/100
Wyckoff phase
Accumulation9d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+20.0%
1 Month
+4.3%
1 Year
+0.0%
RSI
56
Avg daily range
6.8%
EPSILON HEALTHCARE LIMITED scores 27 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 9 trading days. The weekly timeframe reads Accumulation, which agrees with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- RSI in healthy zone (56)
Points to watch
- 60d drawdown -31.0%
- High volatility (ATR 6.8%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
EPN announcements
Recent price-sensitive releases.
- 2026-10-30 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Third Quarter Activity Report | Commitments Test Entity - Third Quarter Cashflow Report
- 2026-08-31 Half Yearly Report and Accounts Half Yearly Report | Half Year Audit Review | Half Year Directors' Statement | Half Year Accounts | Half Year Directors' Report
- 2026-07-30 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Second Quarter Activity Report | Commitments Test Entity - Second Quarter Cashflow Report
- 2026-04-30 Quarterly Activities/Appendix 4C Cash Flow Report
More Health Care stocks
Most traded in the same sector.